Dis-Chem Pharmacies Limited (JSE:DCP)
3,412.00
+128.00 (3.90%)
Jun 19, 2026, 5:00 PM SAST
Dis-Chem Pharmacies Balance Sheet
Financials in millions ZAR. Fiscal year is March - February.
Millions ZAR. Fiscal year is Mar - Feb.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Cash & Equivalents | 499.76 | 585.35 | 884.37 | 287.39 | 705.85 |
Cash & Short-Term Investments | 499.76 | 585.35 | 884.37 | 287.39 | 705.85 |
Cash Growth | -14.62% | -33.81% | 207.73% | -59.28% | 30.78% |
Accounts Receivable | 1,875 | 1,584 | 1,374 | 1,210 | 874.55 |
Other Receivables | 1,791 | 1,557 | 1,174 | 1,191 | 1,169 |
Receivables | 3,745 | 3,256 | 2,674 | 2,615 | 2,265 |
Inventory | 7,908 | 7,905 | 7,163 | 6,357 | 5,759 |
Prepaid Expenses | 188.74 | 198.11 | 201.56 | 189.18 | 124.1 |
Total Current Assets | 12,341 | 11,945 | 10,923 | 9,448 | 8,854 |
Property, Plant & Equipment | 5,826 | 5,297 | 4,800 | 4,429 | 3,689 |
Long-Term Investments | 564.09 | 356.27 | 208.22 | 194.4 | 183.2 |
Goodwill | 948.39 | 925.99 | 929.71 | 873.72 | 790.63 |
Other Intangible Assets | 792.44 | 522.07 | 405.43 | 396.54 | 419.02 |
Long-Term Deferred Tax Assets | 148.38 | 137.5 | 166.37 | 173.94 | 139.62 |
Total Assets | 20,738 | 19,257 | 17,501 | 15,516 | 14,075 |
Accounts Payable | 6,983 | 6,494 | 6,321 | 5,461 | 5,411 |
Accrued Expenses | 558.99 | 544.83 | 436.42 | 453.17 | 620.55 |
Short-Term Debt | 1,949 | 1,676 | 1,237 | 817.48 | 683.64 |
Current Portion of Long-Term Debt | 235.34 | 216.89 | 102.28 | 427.55 | 140.22 |
Current Portion of Leases | 695.21 | 617.85 | 581.83 | 567.04 | 522.23 |
Current Income Taxes Payable | 10.38 | 19.87 | 48.95 | 64.64 | 40.37 |
Current Unearned Revenue | 34.24 | 86.91 | 83.9 | 77.17 | 74.45 |
Other Current Liabilities | 696.67 | 521.63 | 371.41 | 482.27 | 21.82 |
Total Current Liabilities | 11,163 | 10,178 | 9,183 | 8,350 | 7,514 |
Long-Term Debt | 1,510 | 1,679 | 1,282 | 501.48 | 479.17 |
Long-Term Leases | 2,248 | 2,046 | 2,486 | 2,661 | 2,682 |
Long-Term Deferred Tax Liabilities | 123.04 | 125.41 | 74.33 | 70.83 | 13.92 |
Total Liabilities | 15,044 | 14,028 | 13,026 | 11,583 | 10,690 |
Common Stock | 6,156 | 6,156 | 6,156 | 6,156 | 6,156 |
Retained Earnings | 4,179 | 3,723 | 2,965 | 2,355 | 1,776 |
Treasury Stock | -123.24 | -88.63 | -70.08 | -24.62 | -12.17 |
Comprehensive Income & Other | -4,567 | -4,572 | -4,579 | -4,585 | -4,596 |
Total Common Equity | 5,645 | 5,218 | 4,472 | 3,900 | 3,324 |
Minority Interest | 49.46 | 10.75 | 2.82 | 32.09 | 61.71 |
Shareholders' Equity | 5,694 | 5,229 | 4,475 | 3,932 | 3,386 |
Total Liabilities & Equity | 20,738 | 19,257 | 17,501 | 15,516 | 14,075 |
Total Debt | 6,638 | 6,235 | 5,690 | 4,974 | 4,508 |
Net Cash (Debt) | -6,138 | -5,650 | -4,806 | -4,687 | -3,802 |
Net Cash Per Share | -7.16 | -6.58 | -5.60 | -5.45 | -4.42 |
Filing Date Shares Outstanding | 856.11 | 856.97 | 857.35 | 859.27 | 859.75 |
Total Common Shares Outstanding | 856.11 | 856.97 | 857.35 | 859.27 | 859.75 |
Working Capital | 1,178 | 1,767 | 1,740 | 1,098 | 1,340 |
Book Value Per Share | 6.59 | 6.09 | 5.22 | 4.54 | 3.87 |
Tangible Book Value | 3,904 | 3,770 | 3,137 | 2,630 | 2,114 |
Tangible Book Value Per Share | 4.56 | 4.40 | 3.66 | 3.06 | 2.46 |
Land | 1,779 | 1,749 | 1,035 | 490.68 | - |
Machinery | 2,576 | 2,269 | 2,197 | 2,171 | 1,708 |
Leasehold Improvements | 367.43 | 361.51 | 361.21 | 408.73 | 394.89 |